Novel Therapies Targeting Signaling Pathways in Lung Cancer

作者: Adam Yagui-Beltrán , Biao He , Dan Raz , Jae Kim , David M. Jablons

DOI: 10.1016/J.THORSURG.2006.07.001

关键词: Signal transductionEmbryonic stem cellHedgehogMedicineDiseaseCancer researchLungWnt signaling pathwayCarcinogenesisLung cancer

摘要: Despite advances in chemotherapy, the prognosis for advanced non-small-cell lung cancer (NSCLC) remains dismal. Increasing understanding of biological processes responsible carcinogenesis has led to development new therapeutic strategies targeting this disease at a molecular level. This article examines events believed lead cellular changes cancer, and how knowledge these is used develop agents individually or combination with available cytotoxic drugs improve survival. Finally, it explores deeper embryonic signaling pathways airway epithelial repair tumorogenesis, such as Hedgehog (Hh), Notch, Wingless (Wnt), can newer more specific therapies cancer.

参考文章(197)
Ildiko Csiki, Jason D. Morrow, Alan Sandler, Yu Shyr, John Oates, Myles K. Williams, Thao Dang, David P. Carbone, David H. Johnson, Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel. Clinical Cancer Research. ,vol. 11, pp. 6634- 6640 ,(2005) , 10.1158/1078-0432.CCR-05-0436
Robert J. Motzer, M. Dror Michaelson, Bruce G. Redman, Gary R. Hudes, George Wilding, Robert A. Figlin, Michelle S. Ginsberg, Sindy T. Kim, Charles M. Baum, Samuel E. DePrimo, Jim Z. Li, Carlo L. Bello, Charles P. Theuer, Daniel J. George, Brian I. Rini, Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma Journal of Clinical Oncology. ,vol. 24, pp. 16- 24 ,(2006) , 10.1200/JCO.2005.02.2574
Ahmedin Jemal, Freddie Bray, Melissa M. Center, Jacques Ferlay, Elizabeth Ward, David Forman, Global cancer statistics CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 69- 90 ,(1999) , 10.3322/CAAC.20107
Dennis Salonga, Arnulf H. Hölscher, Kathleen D. Danenberg, Ralf Metzger, JiMin Park, Paul M. Schneider, Peter V. Danenberg, Jan Brabender, Epidermal Growth Factor Receptor and HER2-neu mRNA Expression in Non-Small Cell Lung Cancer Is Correlated with Survival Clinical Cancer Research. ,vol. 7, pp. 1850- 1855 ,(2001)
Ruey-Kuen Hsieh, Ken-Hong Lim, Hsu-Tah Kuo, Chin-Yuan Tzen, Ming-Jer Huang, Female Sex and Bronchioloalveolar Pathologic Subtype Predict EGFR Mutations in Non-small Cell Lung Cancer Chest. ,vol. 128, pp. 317- 321 ,(2005) , 10.1378/CHEST.128.1.317
K J O'Byrne, G Cox, J L Jones, Matrix Metalloproteinase 9 and the Epidermal Growth Factor Signal Pathway in Operable Non-Small Cell Lung Cancer Clinical Cancer Research. ,vol. 6, pp. 2349- 2355 ,(2000)
Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Vincent Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, Anna Pluzanska, Ulrich Gatzemeier, John Grous, Judith S. Ochs, Steven D. Averbuch, Michael K. Wolf, Pamela Rennie, Abderrahim Fandi, David H. Johnson, Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1 Journal of Clinical Oncology. ,vol. 22, pp. 777- 784 ,(2004) , 10.1200/JCO.2004.08.001
John D. Minna, Adi F. Gazdar, Shinichi Toyooka, Arvind K. Virmani, Elisabeth Brambilla, Kuniharu Miyajima, Kiyomi O. Toyooka, Kenichi Harada, Luc Girard, Kenji Sugio, Riichiroh Maruyama, Michel Gilcrease, Yutaka Ariyoshi, Takashi Takahashi, DNA methylation profiles of lung tumors. Molecular Cancer Therapeutics. ,vol. 1, pp. 61- 67 ,(2001)